Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human PBMCs: Patients with HSPN vs. Patients with HSP

ABSTRACT: Human PBMCs: Patients with HSPN vs. Patients with HSP

PROVIDER: PRJNA627966 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Human PBMCs: Patients with HSPN vs. Patients with HSP

Project description:Human PBMCs: Patients with HSPN vs. Patients with HSP

| PRJNA627966 | ENA

Human PBMCs: Patients with HSPN vs. Patients with HSP

Project description:Genes that were up-regulated in acute stage in HSPN patients compared with HSP patients, and that showed over 1.5-fold differences by the comparison between the two groups in the mean expression levels were selected.

2020-11-30 | GSE149333 | GEO

Human PBMCs: Healthy vs Diabetic nephropathy vs ESRD

Project description:Human PBMCs: Healthy vs Diabetic nephropathy vs ESRD

| PRJNA595989 | ENA

Human PBMCs: Healthy vs Diabetic nephropathy vs ESRD

Project description:Transcriptional profiling of human PBMCs comparing healthy controls, patients with diabetic nephropathy and patients with ESRD. PBMCs were analyzed as they mediate inflammatory injury. Goal was to determine effects of increasing severity of diabetic nephropathy on global PBMC gene expression. Microarray analysis of PBMCs taken from patients with varying degrees of diabetic nephropathy.

2020-12-01 | GSE142153 | GEO

HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patients

Project description:Stemming from preliminary results obtained by single cell-RNAseq we investigated by qPCR HSP and IFIT gene families in 27 LGLL patients (23 T-LGLL and 4 NK-LGLL), including 11 with neutropenia and/or thrombocytopenia and 16 asymptomatic for the disease. HSP90AA1 and HSPA1B, among HSP family and CD279 exhibit a significantly higher expression in CD3+ CD57+ sorted cells of symptomatic LGLL patients compared to asymptomatic patients and healthy controls. Also, monocytes derived from symptomatic LGLL patients express high levels of CCL3, CCL4 and CCL5 mRNA and of IL-1β, IL-6, TNF, and PD-L1 mRNA, thus confirming a pro-inflammatory cytokine profile reminiscent of a non-classical phenotype. HSP90AA1 and HSPA1B, among HSP family and CD279 exhibit a significantly higher expression in CD3+ CD57+ sorted cells of symptomatic LGLL patients compared to asymptomatic patients and healthy controls. Also, monocytes derived from symptomatic LGLL patients express high levels of CCL3, CCL4 and CCL5 mRNA and of IL-1β, IL-6, TNF, and PD-L1 mRNA, thus confirming a pro-inflammatory cytokine profile reminiscent of a non-classical phenotype. HSP90AA1 and HSPA1B, among HSP family and CD279 exhibit a significantly higher expression in CD3+ CD57+ sorted cells of symptomatic LGLL patients compared to asymptomatic patients and healthy controls. Also, monocytes derived from symptomatic LGLL patients express high levels of CCL3, CCL4 and CCL5 mRNA and of IL-1β, IL-6, TNF, and PD-L1 mRNA, thus confirming a pro-inflammatory cytokine profile reminiscent of a non-classical phenotype.

2024-11-09 | GSE273729 | GEO

Gene expression data from CD34+ BMMCs/PBMCs from MPN patients vs. healthy controls

Project description:Gene expression data from CD34+ BMMCs/PBMCs from MPN patients vs. healthy controls

| PRJNA728082 | ENA

Expression data from human PBMCs from breast cancer patients and controls

Project description:We analyzed gene expression in human peripheral blood mononuclear cells (PBMCs) from breast cancer patients, patients with benign breast abnormalities, healthy cancer-free individuals as well as patients with other types of cancer (gastrointestinal and brain cancers).

2011-03-01 | GSE27562 | GEO

PPD stimulated PBMCs from tuberculosis patients, latent infectious individuals and healthy controls.

Project description:Comprehensively compare the transcriptional difference in PPD stimulated PBMCs from individuals with different tuberculosis infectious status: tuberculosis patients, latent infectious individuals and healthy controls using the microarray analysis. Two-condition experiment, PBMCs vs. PPD-PBMCs. 12 individuals: 4 TB patients, 4 latent infectious individuals and 4 healthy controls.

2012-09-19 | E-GEOD-27984 | biostudies-arrayexpress

PBMCs from metastatic breast cancer patients

Project description:PBMCs from metastatic breast cancer patients

| PRJNA730015 | ENA

Humans PBMCs: Balanced constitution vs. Phlegm-dampness constitution

Project description:Humans PBMCs: Balanced constitution vs. Phlegm-dampness constitution

| PRJNA663843 | ENA